课题基金 / 基金详情

项目摘要

项目成果

William C. Hahn的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The study of DNA tumor viruses that transform rodent and human cells has led to a greater understanding of the molecular events that program the malignant state. In particular, investigation of the viral oncoproteins specified by the Simian Virus 40 Early Region (SV40 ER) has revealed host cell pathways, whose perturbation play an essential role in the transformation of mammalian cells. Over the last several years, we have focused on the role of the SV40 small t antigen (SV40ST) in human cell transformation. During the last funding period, we have confirmed that the interaction between SV40ST and PP2A contributes directly to human cell transformation. In addition, we have found that the perturbation of PP2A by SV40ST transforms human cells in a manner similar to that induced by cancer-associated mutations of PP2A subunits. These observations identify PP2A as a tumor suppressor in human cancers and suggest that a deeper understanding of the mechanisms by which SV40ST perturbs PP2A function will provide additional insights into tumor initiation and maintenance. In order to understand further the role(s) of PP2A in cell transformation, we propose to combine genetic, biochemical and cell biological approaches to characterize the PP2A complexes involved in cell transformation, to identify the role(s) of RalA in cancer development and to elucidate the molecular pathways perturbed by SV40ST and PP2A in human cell transformation. Investigating the regulation and function of PP2A in cancer development will not only enhance our mechanistic understanding of this tumor suppressor family but will also provide new insights into the pathways that help program the malignant state. In addition, these studies will provide a foundation for strategies to target these pathways therapeutically.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of p300/CBP histone acetyltransferase inhibitors for oncogene-driven cancers
  • 批准号:
    10627744
  • 项目类别:
  • 资助金额:
    $65.12万
  • 财政年份:
    2022
  • 负责人:
    William C. Hahn
  • 依托单位:
Novel genetic dependencies in VRK2 methylated glioblastoma multiforme
  • 批准号:
    10046375
  • 项目类别:
  • 资助金额:
    $17.8万
  • 财政年份:
    2020
  • 负责人:
    William C. Hahn
  • 依托单位:
Development and implementation of multiplex methods to understand the biology and heterogeneity of patient-derived cancer models
  • 批准号:
    10004385
  • 项目类别:
  • 资助金额:
    $100.49万
  • 财政年份:
    2020
  • 负责人:
    William C. Hahn
  • 依托单位:
Systematic interrogation of the pancreatic cancer microenvironment in patient-derived specimens
  • 批准号:
    10250566
  • 项目类别:
  • 资助金额:
    $56.84万
  • 财政年份:
    2017
  • 负责人:
    William C. Hahn
  • 依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究